EUVIMEDEUVIMED entdecken
Open Access

Rilpivirine Ionic Liquid Nanoemulsion Augments the Oral Bioavailability of Rilpivirine and Its Delivery to the HIV Sanctuary Sites

Yogesh Sutar, Joseph S Adams, Xiangmeng Wu, Vaibhavi Bhoyarekar, Monica Garcia Diaz, Jennillee Wallace, Masumi Dave, Qing-Yu Zhang, Abhijit A Date iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c05456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Yogesh Sutar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States. Hauptthemen laut MEDLINE: Rilpivirine, HIV Infections, Ionic Liquids, Anti-HIV Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, University of Arizona, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RilpivirineHIV InfectionsIonic LiquidsAnti-HIV AgentsNanoparticlesAnimalsEmulsionsMiceBiological AvailabilityAdministration, OralHumansTissue DistributionSolubility

Stichwörter der Autor:innen

Capryol 90HIV reservoirsLabrafac MC60Transcutolnanoemulsion

Substanzen

RilpivirineEmulsionsIonic LiquidsAnti-HIV Agents

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States.
  • Gattefossé Corporation, Paramus, New Jersey 07652, United States.
  • Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, Illinois 60612, United States.
  • Department of Ophthalmology and Vision Science, University of Arizona College of Medicine, Tucson, Arizona 85711, United States.

ORCID-Profile: Abhijit A Date

Förderung

  • NIAID NIH HHS
  • University of Arizona
  • National Institute of Allergy and Infectious Diseases
  • R.K. Coit College of Pharmacy

Zitieren

APA

Sutar, Y., Adams, J. S., Wu, X., Bhoyarekar, V., Garcia Diaz, M., Wallace, J., Dave, M., Zhang, Q. Y., & Date, A. A. (2025). Rilpivirine Ionic Liquid Nanoemulsion Augments the Oral Bioavailability of Rilpivirine and Its Delivery to the HIV Sanctuary Sites. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c05456

Vancouver

Sutar Y, Adams JS, Wu X, Bhoyarekar V, Garcia Diaz M, Wallace J, et al. Rilpivirine Ionic Liquid Nanoemulsion Augments the Oral Bioavailability of Rilpivirine and Its Delivery to the HIV Sanctuary Sites. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c05456

BibTeX
@article{Sutar2025,
  author = {Sutar, Yogesh and Adams, Joseph S and Wu, Xiangmeng and Bhoyarekar, Vaibhavi and Garcia Diaz, Monica and Wallace, Jennillee and Dave, Masumi and Zhang, Qing-Yu and Date, Abhijit A},
  title = {Rilpivirine Ionic Liquid Nanoemulsion Augments the Oral Bioavailability of Rilpivirine and Its Delivery to the HIV Sanctuary Sites},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c05456}
}
Kostenlos starten →